MedPath

To compare Ropivcaine Versus Bupivacaine intrapeitoneal instillation in postoperative pain relief in laparoscopic cholecystectomy.

Not Applicable
Conditions
Health Condition 1: K807- Calculus of gallbladder and bile duct without cholecystitis
Registration Number
CTRI/2023/06/053604
Lead Sponsor
Dr SWAPNA LAKSHMI PRIYA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ASA GRADE I AND II PATIENTS.

AGES BETWEEN 18 TO 65 YEARS OF EITHER SEX.

AVAILABILITY OF RETURN INFORMED CONBSENT.

PATIENTS UNDERGOING LAPAROSCOPIC CHOLECYSTECTOMY UNDER GENERAL ANESTHESIA.

HEMODYNAMICALLY STABLE PATIENTS WITH ALLL ROUTINE INVESTIGATIONS WITHIN NORMAL LIMITS.

Exclusion Criteria

PATIENTS WITH ASA PHYSICAL STATUS III OR MORE.

PATIENTS BELOW 18 YEARS AND ABOVE 65 YEARS.

PATIENTS POSTED FOR EMERGENCY PROCEDURES.

PATIENTS WITH MAJOR NEUROLOGICAL,CARDIAC,RESPIRATORY,RENAL,METABOLIC,HEPATIC DISEASES OR WITH COAGULATION ABNORMALITY.

PATIENTS WITH KNOWN ALLERGIC TO STUDY DRUG.

PATIENTS UNWILLING TO GET ENROLLED.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
TO COMPARE THE EFFECTIVENESS OF 0.375% ROPIVACAINE[35ML] IN INTRAPERITONEAL INSTILLATION FOR POSTOPERATIVE ANALGESIA IN LAPAROSCOPIC CHOLECYSTECTOMY.Timepoint: T0-IMMEDIATE POST OPERATIVELY, <br/ ><br>T1-HOURLY TILL 4HOURS <br/ ><br>T2-EVERY 4TH HOURLY UPTO 12 HOURS. <br/ ><br>T3-EVERY 6TH HOURLY UPTO 24 HOURS
Secondary Outcome Measures
NameTimeMethod
TO COMPARE THE EFFECTIVENESS OF 0.25%BUPIVACAINE[35ML] IN INTRAPERITONEAL INSTILLATION FOR POSTOPERATIVE ANALGESIA IN LAPAROSCOPIC CHOLECYSTECTOMY.Timepoint: T0-IMMEDIATE POST OPERATIVELY, <br/ ><br>T1-HOURLY TILL 4HOURS <br/ ><br>T2-EVERY 4TH HOURLY UPTO 12 HOURS. <br/ ><br>T3-EVERY 6TH HOURLY UPTO 24 HOURS
© Copyright 2025. All Rights Reserved by MedPath